TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Edwards Lifesciences Nordic AB
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
526,379
|
466,287
|
438,467 |
| Financial expenses |
2,009
|
985
|
582 |
| Earnings before taxes |
20,822
|
22,937
|
14,905 |
| EBITDA |
22,708
|
23,997
|
15,740 |
| Total assets |
165,901
|
168,661
|
151,180 |
| Current assets |
165,163
|
168,246
|
150,517 |
| Current liabilities |
74,325
|
96,594
|
93,772 |
| Equity capital |
88,170
|
68,813
|
50,425 |
| - share capital |
101
|
95
|
98 |
| Employees (average) |
36
|
31
|
34 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
53.1%
|
40.8%
|
33.4% |
| Turnover per employee |
14,622
|
15,042
|
12,896 |
| Profit as a percentage of turnover |
4.0%
|
4.9%
|
3.4% |
| Return on assets (ROA) |
13.8%
|
14.2%
|
10.2% |
| Current ratio |
222.2%
|
174.2%
|
160.5% |
| Return on equity (ROE) |
23.6%
|
33.3%
|
29.6% |
| Change turnover |
27,006
|
40,998
|
18,664 |
| Change turnover % |
5%
|
10%
|
4% |
| Chg. No. of employees |
5
|
-3
|
0 |
| Chg. No. of employees % |
16%
|
-9%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.